Table 3.
Markers | Negative | Positive | Total | Combo values | ||
---|---|---|---|---|---|---|
Gal-3 | Benign | 34 | 10 | 44 | Sensitivity | 0.926 |
Malignant | 2 | 25 | 27 | Specificity | 0.773 | |
PPV | 0.714 | |||||
Total | 36 | 35 | 71 | NPV | 0.944 | |
Ret | Benign | 30 | 14 | 44 | Sensitivity | 0.852 |
Malignant | 4 | 23 | 27 | Specificity | 0.682 | |
PPV | 0.622 | |||||
Total | 34 | 37 | 71 | NPV | 0.882 | |
HBME-1 | Benign | 32 | 12 | 44 | Sensitivity | 0.889 |
Malignant | 3 | 24 | 27 | Specificity | 0.727 | |
PPV | 0.667 | |||||
Total | 35 | 36 | 71 | NPV | 0.914 | |
CK19 | Benign | 31 | 13 | 44 | Sensitivity | 0.852 |
Malignant | 4 | 23 | 27 | Specificity | 0.705 | |
PPV | 0.639 | |||||
Total | 35 | 36 | 71 | NPV | 0.886 |
Gal-3-Galectin-3; Ret-Ret oncoprotein; CK 19-Cytokeratin 19; PPV-Positive predictive value; NPV-Negative predictive value